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Objective: A multisite ﬁeld trial testing whether improved outcomes associated with intensive referral to
mutual help groups (MHGs) could be maintained after the intervention was adapted for the
circumstances and needs of rural veterans in treatment for substance use disorder (SUD).
Methods: In three Veterans Affairs treatment programs in the Midwest, patients (N = 195) received
standard referral (SR) or rural-adapted intensive referral (RAIR) and were measured at baseline and 6month follow-up.
Results: Both groups reported signiﬁcant improvement at 6-months, but no signiﬁcant differences
between SR and RAIR groups in MHG participation, substance use, addiction severity, and posttraumatic
stress symptoms. Inconsistent delivery of the intervention resulted in only one-third of the RAIR group
receiving the full three sessions, but this group reported signiﬁcantly greater 6-month abstinence from
alcohol than those receiving no sessions.
Conclusion: Further research should explore implementation problems and determine whether
consistent delivery of the intervention enhances 12-step facilitation.
Practice implications: The addition of rural-speciﬁc elements to the original intensive referral intervention
has not been shown to increase its effectiveness among rural veterans.
© 2017 Elsevier B.V. All rights reserved.
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1. Introduction
Nearly all service members deployed to Iraq and Afghanistan
report facing hostile incoming ﬁre (97%), but most also face
additional traumas and stressors, including seeing people begging
for food (97%), concern about enemy attack (77%), and concern
about family and friends on the homefront (54%)[1]. An estimated
40% report substantial reintegration problems, including difﬁculty
conﬁding personal thoughts (56%) and controlling anger (57%) [2].
An estimated 41% may have had post-traumatic stress disorder
(PTSD) and 38% an alcohol use problem [2]. Approximately onethird of community samples seeking SUD treatment have co-

* Corresponding author at: Western Illinois University, Quad Cities, 3300 River
Drive, Moline, IL 61265, USA.
E-mail address: LB-Young@wiu.edu (L.B. Young).
http://dx.doi.org/10.1016/j.pec.2017.07.012
0738-3991/© 2017 Elsevier B.V. All rights reserved.

morbid post-traumatic stress disorder (PTSD) [3] and the
prevalence among veterans is likely higher [4].
Treatment for substance use disorders requires time. Patients
show better outcomes with contact over a 12-month period,
including 3 to 6 months of continuing care [5]. Post-treatment
continuing care involves lower-intensity engagement in an
outpatient setting [5], and it is helps prevent relapse after
intensive SUD treatment [6]. Social support is a primary
component of continuing care, and a protective factor for SUD
treatment relapse [7] and post-deployment traumatic stress
symptoms [8].
A mutual-help group (MHG) is any group of individuals who
meet regularly to share experiences managing a common problem.
Social support provided by MHGs like Alcoholics Anonymous and
other 12-step groups improves outcomes [6,9], even for those with
concurrent PTSD and SUD [10], and efforts to promote participation reduce continuing care costs [7]. Post-treatment referral to
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mutual-help groups has been described as “an effective, low-cost
option” [8] but treatment providers vary in consistency and
methods of referral [11].
Rural veterans have disproportionately served in Operation
Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) [12]
and are returning to their communities with signiﬁcant substance
use disorder (SUD) and trauma-related symptoms [13,14]. However, rural veterans have less access than non-rural veterans to
continuing care in an outpatient setting [15,16]. Additionally, rural
veterans attending MHG meetings are likely to have challenges
unique to their rural settings. In rural communities veterans are
more likely to be recognized by others [17,18] and rural residents
rate MHGs as less acceptable than urban residents do [19]. Further,
the only mutual-help groups consistently available in many small
or rural communities are AA meetings which may cause some
ambivalence in those with problems other than alcohol [20]. In
short, MHG referral does not occur in a standardized way and rural
residents facing barriers to accessing continuing care may also face
barriers to engaging with MHGs.
The purpose of this study is to determine whether a structured,
intensive referral to mutual-help groups can be adapted to the
circumstances of rural veterans while maintaining effectiveness. In
a study of urban veterans leaving treatment, Timko and
DeBenedetti [21] found 1-year SUD abstinence rates improved
more than 24% with a three-step intensive referral intervention
which (1) educated patients on the beneﬁts of mutual-help groups,
(2) identiﬁed an upcoming local meeting and recovery buddy to
accompany the patient, and (3) followed up on attendance [22]. For
those with a dual-diagnosis of SUD and PTSD, this intensive referral
intervention was associated with an 18% reduction in the number
of psychiatric symptoms and a 26% reduction in perceived need for
mental health treatment [23].
During typical intensive residential SUD treatment, veterans
attend nearby mutual-help meetings, develop sober relationships,
and obtain a sponsor, who serves as a mentor providing advice and
assistance. Urban and suburban patients often live near their
treatment center and can maintain those relationships upon
transitioning to the home environment, but rural patients typically
do not live within commuting distance. Upon discharge, rural
veterans return to communities without these supports, and are at
higher risk of relapse [24,25]. Family members are another source
of social support preventing SUD relapse [26,27]. Family members
are encouraged to support treatment by attending regular sessions

which prepare them for the relational turbulence which accompanies recovery. Family members of rural veterans are less likely to
attend family sessions and typically have no support themselves
[28], thus rural veterans may not receive the same family support
beneﬁts that urban veterans do [28].
The current study tests a rural-adapted intensive referral (RAIR)
which modiﬁes the original intensive referral intervention by
identifying an MHG meeting and recovery buddy in the home
community and educating family members on the importance of
MHG participation. We tested the following hypotheses in a
multisite ﬁeld trial: Compared to the control condition of standard
referral, RAIR will be associated with more MHG afﬁliation, less use
of alcohol and other drugs, and reduced PTSD symptomology. To
our knowledge, this is the ﬁrst evidence-based substance use
intervention modiﬁed for rural veterans.
The RAIR intervention consisted of three sessions and resources
including a ﬂowchart for each session, handouts, a self-help
journal, and a list with meeting locations and mutual-help buddies
in towns throughout the region. (Materials are available from the
corresponding author.) This list of meetings and buddies covered
each recruitment site as well as rural communities of central and
eastern Nebraska. The sessions provided a trajectory for fully
integrating clients into a recovery network, but staff were given
ﬂexibility to adapt to each client’s familiarity with MHGs and need
for support.
The initial face-to-face session took place either in individual or
in group sessions. Staff assessed participants’ knowledge and
experience of MHGs, explained the importance of meeting
attendance (handout 1), scheduled a MHG meeting to attend
before the next session, arranged for the client to meet a MHG
buddy at that meeting, provided a journal to record experiences,
and sought permission to contact a family member (family
handout mailed to the family member).
The subsequent two sessions followed-up on MHG attendance
and participation and could be completed in person or by phone.
The second session addressed whether and why MHG attendance
and buddy contacts were successful. Expectations for MHG
meeting behaviors were discussed (handout 2), and if buddy or
family support was still needed, contact efforts were undertaken.
The third session was similar, but the focus shifted to troubleshooting participation barriers (handout 3) and planning for
sponsorship, service, and other forms of MHG participation
(handout 4). The original intensive referral intervention [21]

Table 1
Baseline Characteristics of Standard and Intensive Referral Patients.

Male, N (%)
Caucasian, N (%)
Hispanic, N (%)
Married, N (%)
Rural City or Town, N (%)
Age, M (SD)
AAAS Score, M (SD)
Attended MHG ever, N (%)
Attended MHG past year, N (%)
# Meetings in past year, M (SD)
PTSD Checklist, M (SD)
ASI-L alcohol, M (SD)
ASI-L drug use, M (SD)
30-day substance use
Alcohol, N (%)
Cannabis, N (%)
Methamphetamine, N (%)
Cocaine or crack, N (%)

Total
(N = 195)

Standard
(n = 89)

RAIR
(n = 106)

X2/t

p

178 (91.3%)
150 (76.9%)
11 (5.6%)
53 (27.2%)
61 (31.3%)
46.86 (12.25)
4.69 (1.96)
193 (99.0%)
190 (97.9%)
45.56 (74.46)
46.66 (18.02)
.39 (.27)
.09 (.11)

83 (93.3%)
69 (77.5%)
7 (7.9%)
26 (29.2%)
22 (24.7%)
46.37 (12.64)
4.64 (2.08)
88 (98.9%)
85 (96.6%)
42.75 (65.19)
45.05 (18.18)
.43 (.27)
.07 (.10)

95 (89.6%)
81 (76.4%)
4 (3.8%)
27 (25.5%)
39 (36.8%)
47.26 (11.96)
4.74 (1.87)
105 (99.1%)
105 (99.1%)
47.89 (81.60)
48.01 (17.87)
.37 (.27)
.10 (.12)

.80
.03
1.52
.34
3.28
.51
.33
.02
1.45
.48
1.15
1.51
1.87

.37
.85
.22
.56
.07
.61
.74
.90
.23
.63
.25
.13
.06

137 (70.3%)
47 (24.1%)
27 (13.8%)
24 (12.3%)

66 (74.2%)
15 (16.9%)
10 (11.2%)
8 (9.0%)

71 (67.0%)
32 (30.2%)
17 (16.0%)
16 (15.1%)

1.19
4.70
.94
1.67

.28
.03
.33
.20

Note: RAIR = rural-adapted intensive referral; MHG = mutual-help group. M = mean; SD = standard deviation.
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relied on the same MHG buddies to provide support to the patient
during and after treatment, whereas rural RAIR participants might
have one buddy during treatment and a different one on returning
to their home community.
2. Materials and methods
2.1. Research design
This ﬁeld trial used a pretest-posttest quasi-experimental
design. Patients entering treatment were assigned to an addiction
therapist (AT), half of whom had been trained in RAIR. Those not
trained in RAIR provided their standard referral (SR), typically a
recommendation to ﬁnd and attend MHG meetings upon
completing residential/intensive outpatient treatment, although
referral practices vary [11]. Patents were pretested at baseline and
followed-up six months later on measures of mutual-help group
afﬁliation, substance use, and PTSD.
2.2. Sampling
The Institutional Review Board of the Department of Veterans
Affairs (VA) Nebraska-Western Iowa Health Care System (VA
NWIHCS) approved and monitored human subjects’ participation.
Participants were enrolled from three VA intensive SUD treatment
sites in Nebraska that serve rural and urban veterans. Zip code of
residence prior to treatment entry determined rural/urban status
utilizing Rural-Urban Commuting Area codes [29].
Eligibility criteria included being at least 19 years of age and
having no evidence of cognitive impairment on the Mini-Cog [30].
Those who provided informed consent were enrolled. In-person
baseline interviews collected data on demographic characteristics,
addiction severity, social support, traumatic events and symptomology, and mutual-help group participation. Six-month followup interviews were done in-person or by telephone. Data
collection began March, 1, 2013, and concluded December 11, 2014.
A total of 195 participants enrolled and provided baseline data
for analysis. Their characteristics are provided in Table 1. Reﬂective
of the region’s veteran population, the baseline sample overall was
middle-aged and mostly male, white, non-Hispanic, and unmarried. Sixty-one (31.3%) provided residential zip codes qualifying as
rural city or town, with no signiﬁcant difference between SR and
RAIR groups. The Alcoholics Anonymous Afﬁliation Scale (AAAS)
revealed widespread exposure to MHGs at baseline. The mean
PTSD Checklist (PCL) score of 46.66 (SD = 18.02) was just below the
VA’s recommended threshold of 50.00 for a PTSD diagnosis.
Very low drug severity subscores on the Addiction Severity
Index-Lite (ASI-L; Table 1) suggest baseline alcohol use was more
problematic than drug use. More than two-thirds of participants
had consumed alcohol within 30 days of baseline and nearly one
quarter had consumed cannabis. Use of methamphetamine and
cocaine/crack was reported by a minority of participants, but other
substances (e.g. opiates, stimulants, etc.) were either not reported
or used by less than 10% of participants at baseline and therefore
not analyzed. Those assigned to the RAIR condition did not differ
signiﬁcantly from those receiving SR, with the exception that a
greater percentage of those assigned to RAIR than to SR had
consumed cannabis (30% vs. 17%, p = .03).
2.3. Instruments used
The independent variable was type of assignment at baseline:
standard referral (SR) or rural-adapted intensive referral (RAIR).
Patients in RAIR, however, did not consistently receive the full
intervention, so additional exploratory analysis compared those
who received no RAIR sessions with those who received the full 3
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sessions of RAIR. Additional analysis tested for a dose effect among
those receiving no sessions, 1–2 sessions, and 3 sessions.
The dependent variable of MHG afﬁliation was determined by
responses to the Alcoholics Anonymous Afﬁliation Scale (AAAS)
[31], modiﬁed to include a range of 12-step MHGs. Total scores
range from 0 to 9, with higher scores indicating greater afﬁliation.
The measure shows adequate reliability and validity [31,32]. In this
sample, the measure displayed adequate reliability, as measured
by Cronbach’s alpha, at both baseline (a = 0.71) and follow-up
(a = 0.77).
Substance use was measured several ways. The Timeline
Follow-Back (TLFB) measure [33] documents frequency and
quantity of use of a variety of substances during the previous
30 days. Outcome measures included percent days abstinent and
use per using day for each substance.
The Addiction Severity Index-Lite (ASI-L) [34] also measured
severity of use for alcohol (ASI-L alcohol) and for other drugs (ASI-L
drug use). Scores in each domain range from 0 to 1. The ASI-L
alcohol subscale includes six items and yielded Cronbach’s alpha of
0.88 for the baseline measure. The ASI-L drug use subscale includes
11 items addressing an array of drugs other than alcohol and also
yielded satisfactory baseline reliability (a = 0.78).
The PTSD checklist [35] consists of 17 questions relating to three
PTSD symptoms: intrusive thoughts (5 items), avoidance (7 items),
and hyperarousal (5 items). Possible scores range from 17 to 85,
with higher scores indicating greater symptom severity. Reliability
using Cronbach’s alpha was excellent (a = 0.95).
2.4. Data collection and procedures
Patients received standard referral or RAIR depending on the
addiction therapist (AT), with caseload typically determining who
was assigned each incoming patient. Veterans were approached
for study participation after initial admission assessments were
completed, precluding random assignment and more closely
approximating ‘real world’ procedures of SUD treatment programs.
Eleven ATs (six males and ﬁve females) staffed the three
recruitment sites. All ATs were educated about the rationale for
RAIR and were encouraged to notify the Principal Investigator of
their interest in being trained in RAIR. Three males and two
females were trained in RAIR. An equal number of staff at each site
with master’s degrees were trained in RAIR or provided SR.
Scheduling demands and AT specialization precluded randomization.
The intervention group received RAIR from their AT, a peer
support specialist (PSS), or physician trained in the intervention.
Initially, the PI (a physician) trained the RAIR ATs in the
intervention using role plays and group sessions with veterans.
It became evident that the RAIR-trained ATs did not consistently
have time to perform RAIR and a study published in late 2012
showed referral to 12-step support groups was signiﬁcantly more
effective when delivered by peers than by clinicians [36]. Given
this evidence for enhanced effectiveness, we trained PSSs to
perform the intervention.

2.5. Data analysis
Data were entered into SPSS Statistics version 22.0 (IBM Corp.,
Armonk, New York). Data analysis included Pearson’s chi-square
analysis, independent samples t-test, and analysis of covariance
(ANCOVA). Two-tailed tests were used throughout and the
threshold for a type I error was p < 0.05. Two hundred and two
individuals were consented for study participation, but we have
baseline data on only 195 participants and follow-up data on 140.
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Table 3
Follow-up Mutual-help Group Involvement, Substance Use, and PTSD: Intention-toTreat.

3. Results
3.1. Primary outcomes
Of the 195 baseline enrollees, 140 (72%) were successfully
followed-up at six months. Those followed-up were older
(M = 48.39, SD = 12.54) than those not followed-up (M = 42.96,
SD = 10.62, p = .005). Otherwise, ethnicity, marital status, MHG
participation, PTSD symptomology, addiction severity, and 30-day
substance use measured at baseline did not signiﬁcantly differ
between those who were and were not followed up (results not
shown).
Initial tests were conducted to determine the effectiveness of
SUD treatment overall for the entire sample. As shown in Table 2,
participants signiﬁcantly improved on most measures of MHG
involvement, substance use, and PTSD. The improvements did not
reach statistical signiﬁcance in use per using day for alcohol and
cannabis (not reported) and in the percent of participants
abstinent from cannabis. Insufﬁcient sample size of those
reporting drug use prevented statistical comparison of use per
using day for methamphetamine and cocaine in this analysis, and
for cannabis, methamphetamine, and cocaine in subsequent
analyses.
Those assigned to SR and to RAIR were compared across an
array of mutual-help group and substance use outcome variables
(Table 3). For continuous variables, test statistics were calculated
using ANCOVA with the baseline value of the variable entered as a
control and the follow-up value used as the dependent variable.
The remaining ANCOVAs showed no signiﬁcant differences,
suggesting assignment to the SR or RAIR group was not associated
with substance use or MHG participation. The groups were also
compared on the percent reporting abstinence from alcohol and
from other drugs in the 30 days prior to the follow-up interview.
Chi-square analysis revealed no signiﬁcant difference between the
groups.
Not all those assigned to receive RAIR actually received all three
prescribed sessions. Of the 106 participants assigned to the RAIR
condition at baseline, only 61 (58%) received the ﬁrst session and
fewer received the second (N = 38, 36%) and third sessions (N = 27,
26%). Veterans are assigned to levels of SUD treatment utilizing the
American Society of Addiction Medicine Patient Placement
Criteria. The veterans eligible for this study (those in residential
or intensive outpatient treatment) were severely impaired and had
Table 2
Mutual-help Group Involvement, Substance Use, and PTSD: Before and After
Treatment for Entire Sample.
Dependent Variable

AAAS Score
# Meetings in recent months
# Other 7 MHG behaviors
PTSD Checklist
ASI-L Alcohol
ASI-L Drug Use
Percent days abstinent
Alcohol
Cannabis
Methamphetamine
Cocaine
Use per using day
Alcohol (n = 25): # drinks
Participants abstinent
From alcohol
From other drugs

Baseline

Follow-up

Paired t-test

Mean SD

Mean

SD

d.f.

t

p

4.64
42.72
3.70
45.87
.40
.08

5.37
69.07
4.17
36.09
.17
.03

2.15
66.00
1.83
18.65
.18
.05

136
137
139
136
134
136

4.32
3.87
3.11
7.00
9.55
6.85

.00
.00
.00
.00
.00
.00

60.91
90.38
94.44
96.59

20.16
N
38
83

1.98
69.59
1.70
18.34
.26
.11

37.09
25.11
19.44
13.86

23.53
%
27.1
59.3

92.37
98.59
99.90
100.00

14.67
N
114
127

21.46
10.22
1.13
N/A

17.53
%
81.4
90.7

Note: N = 140; paired-samples t-tests. SD = standard deviation.

138
138
138
138

24
d.f.
1
1

9.76
3.89
3.38
2.90

1.01
X2
8.76
2.58

.00
.00
.00
.00

.32
p
.00
.11

Dependent Variable

Standard
(n = 63)
Mean

SD

Mean

SD

d.f.

F

p

AAAS Score
# Meetings in 6 months
# Other 7 MHG behaviors
PTSD Checklist
ASI-L Alcohol
ASI-L Drug Use

5.26
65.26
4.11
34.87
.16
.02

2.21
72.99
1.85
19.55
.17
.04

5.48
72.12
4.21
37.21
.17
.03

2.10
60.13
1.82
17.85
.19
.06

1
1
1
1
1
1

.04
.08
.17
.02
.25
.82

.85
.78
.68
.89
.62
.37

Percent days abstinent
Alcohol
Cannabis
Methamphetamine
Cocaine

92.43
99.95
100.00
100.00

21.19
.42
.00
.00

92.42
97.49
99.83
100.00

21.69
13.67
1.52
.00

1
1
1
1

.00
1.49
.38
N/A

.99
.22
.54
N/A

Use per using day
Alcohol (N = 25): # drinks
Participants abstinent
From alcohol
From other drugs

11.47
N
51
60

5.94
%
81.0
95.2

17.63
N
63
67

23.71
%
81.8
87.0

1
d.f.
1
1

.51
X2
.02
2.78

.49
p
.90
.10

RAIR
(n = 77)

ANCOVA

Note: The control variable for each ANCOVA is the baseline measure of the
dependent variable. SD = standard deviation.

the greatest treatment needs, often having multiple prior SUD
treatments. Their ATs reported that the time required for
addressing the severity of their addiction and its sequelae
prevented them from consistently performing RAIR. We therefore
performed exploratory analyses using as the control group all who
received no RAIR sessions and using as the intervention group
those who received all three sessions, as the intervention was
designed. The “no sessions” control included both those who were
assigned to receive SR, and those assigned to receive RAIR but who
did not receive any sessions. Results (Table 4) indicate only one
statistically signiﬁcant difference between those receiving no RAIR
sessions and those receiving all three. The percentage of
participants reporting 30-day abstinence from alcohol was
signiﬁcantly higher in the 3-session group than in the zerosession group (96% vs. 78%, p = .03).

Table 4
Follow-up Mutual-help Group Involvement, Substance Use, and PTSD: Actually
Treated.
Dependent Variable

No Sessions
(n = 91)
Mean

AAAS Score
# Meetings in 6 months
# Other 7 MHG behaviors
PTSD Checklist
ASI-L Alcohol
ASI-L Drug Use

5.40
67.61
4.20
36.20
.17
.03

Percent days abstinent
Alcohol
Cannabis
Methamphetamine
Cocaine
Use per using day
Alcohol (n = 20): # drinks
Participants abstinent
From alcohol
From other drugs

3 Sessions
(n = 26)

ANCOVA

SD

Mean

SD

d.f.

F

p

2.14
69.48
1.80
20.27
.18
.05

5.33
71.12
4.08
33.16
.15
.03

2.33
45.99
2.10
15.13
.18
.05

1
1
1
1
1
1

.00
.02
.05
1.74
.04
.06

.98
.90
.82
.19
.84
.80

91.32
99.71
100.00
100.00

21.83
1.62
.00
.00

96.15
96.15
99.49
100.00

19.61
19.61
2.61
.00

1
1
1
1

.70
3.51
N/A
N/A

.41
.06
N/A
N/A

17.05
N
71
84

19.40
%
78.0
92.3

16.0
N
25
23

N/A
%
96.2
88.5

1
d.f.
1
1

.00
X2
4.51
.38

.99
p
.03
.54

Note: The control variable for each ANCOVA is the baseline measure of the
dependent variable. SD = standard deviation.

K.M. Grant et al. / Patient Education and Counseling 101 (2018) 79–84

3.2. Additional exploratory analyses
RAIR was not designed to be dose-speciﬁc, but we tested for a
dose effect by placing participants in three dose categories: no
sessions, partial (1–2 sessions), or full (3 sessions). Results revealed
no signiﬁcant between-groups differences (results not shown).
Finally, RAIR was designed to increase MHG participation across
a range of attitudes and behaviors, so we compared the no RAIR
and full RAIR groups on individual AAAS items: attending
meetings, identifying as a member, calling members for help,
having a sponsor, being a sponsor, having a spiritual awakening,
reading literature, and providing service. We found no signiﬁcant
differences on these attitudes and behaviors (results not shown).
4. Discussion and conclusion
This ﬁeld trial of a rural-adapted intensive referral to mutual
help-groups found no signiﬁcant difference between the RAIR and
SR groups in any of the dependent variables. Compared to the nosessions group, those receiving the full 3-sessions of RAIR showed
no additional improvement on measures including MHG participation, PTSD symptoms, addiction severity, percent days abstinent,
and alcohol use per using day. A signiﬁcantly higher proportion of
those who received the intervention as designed, however, were
abstinent from alcohol at follow-up. Potential explanations will be
considered.
First, the high level of baseline MHG participation among this
sample is noteworthy because it leaves less room for improvement.
In their six-month outcomes for the original intensive referral
intervention, Timko, DeBenedetti, and Billow [37] reported six
measures of baseline 12-step afﬁliation for their sample entering
an urban VA outpatient SUD treatment facility. The sample in the
present (RAIR) study was higher than the 2006 study on ﬁve of the
behaviors: being a sponsor (11.3% vs. 7.0%), having a spiritual
awakening (46.9% vs. 44.9%), reading MHG literature (96.4% vs.
81.3%), providing service (60.5% vs. 50.6%), and ever attending a
meeting (99.0% vs. 96.8%). The present (RAIR) study reported lower
rates than the 2006 study of having a sponsor (32.3% vs. 55.4%),
perhaps because ﬁnding sponsors in rural areas is more challenging.
Baseline MHG behaviors reported in the present sample and in
the earlier research on intensive referral indicate the majority of
veterans entering SUD treatment have ﬁrst-hand experience with
MHGs. The present sample, in particular, may require less of the
basic MHG education that RAIR provides and more of the direct
assistance coordinating support. The three study sites were
employing Twelve Step Facilitation (TSF) as one of their
evidence-based treatment modalities, perhaps making it difﬁcult
to improve upon this threshold of 3–4 MHGs per month reported
by the participants at baseline.
Second, as in the present RAIR study, the original intensive
referral study [37] also found no difference between SR and
intervention groups on MHG meeting attendance, reading literature, or being a sponsor. Unlike RAIR, that earlier study resulted in
higher rates of having a sponsor, having a spiritual awakening, and
providing service when compared to SR. Yet, when compared to
the SR group in the present RAIR study, that 2006 research on
intensive referral at six month follow-up had lower rates on ﬁve
measures of MHG participation common to both studies: having a
sponsor, previously being a sponsor, having a spiritual awakening,
reading literature, and providing service. Meeting attendance
measures were not directly comparable, but did not appear to
diverge substantially. The Timko et al. [37] study achieved greater
reductions in ASI drug use than did the present study’s SR, but a
smaller reduction in ASI alcohol. These comparisons suggest RAIR’s
comparison group achieved results at least comparable to the
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original intensive referral. Rather than suggesting intensive
referral is ineffective, the results suggest that standard referral
in the Nebraska VA treatment centers is as effective as intensive
referral, both in its original form and in the rural-adapted intensive
referral. Another possible explanation is that referral to MHGs is
more common today than it was a decade ago.
Third, the preliminary ﬁnding that a signiﬁcantly higher
percentage of 3-session RAIR participants were abstinent from
alcohol in comparison to those who received no RAIR sessions (96%
vs. 81%) suggests the intervention has some effect, even if the
mechanism is unclear. Neither the AAAS scores nor any individual
AAAS behavior signiﬁcantly differed between the groups, yet a
signiﬁcantly higher percentage of alcohol-abstinent participants
was documented in the 3-session RAIR group. Similar ﬁndings
were reported in an effectiveness study of Making AA Easier
(MAAEZ), a six-week, manual-guided intervention with goals
similar to RAIR. In studying the mediating role of various 12-Step
behaviors and attitudes, Subbaraman, Kaskutas, and Zemore [38]
found that only MHG service work mediated MAAEZ’s effect on
abstinence in the overall sample. If a greater proportion of people
remain abstinent even when they are not engaging more
frequently than others in MHG behaviors, then the mechanism
motivating abstinence is either a MHG behavior or attitude which
has not been measured or, more likely, some aspect of the referral
program is motivating abstinence. Future research should consider
whether the active ingredient is, for instance, reinforcing abstinence as a goal [39] or expanding the sober social network via the
group format [40].
Finally, this was the ﬁrst multisite ﬁeld trial of intensive referral
and although the staff were trained and routinely monitored for
ﬁdelity, they did not consistently deliver the sessions. A full
implementation study is forthcoming, but a primary implementation barrier cited by the staff was the amount of time required to
deliver the intervention, particularly the ﬁrst session, delivered to
only 58% of assigned participants. The limited time patients spend
with an addiction therapist frequently focuses on solving problems
which may not directly relate to post-treatment social support.
Future research should consider the effectiveness of intensive
referral in varied contexts. For instance, is intensive referral more
effective in treatment centers relying on cognitive behavioral
therapy rather than on TSF? The components of the intervention,
and especially the adaptations we integrated, should be examined
for efﬁcacy vis-à-vis the time required to deliver them and the
alternative SR procedures.
Limitations of the study include inconsistent implementation
and enrollment in an exclusively veteran population potentially
limiting generalizability. Those who received RAIR may have been
inﬂuenced by the individual delivering it, by mode of delivery, or
by some other variable not measured. A signiﬁcantly higher
proportion of cannabis users was assigned to receive RAIR, which
may have affected the results, given that Alcoholics Anonymous
and most other MHGs accessible to rural and urban veterans alike
do not focus on problems with marijuana.
5. Conclusion
At six-month follow-up, rural-adapted intensive referral and
standard referral groups did not differ on measures of substance
use, mutual-help group attendance or participation, or posttraumatic stress symptoms. Additional analyses comparing those
receiving no RAIR sessions to the minority who received the
intervention as designed likewise found no differences, with one
exception: those receiving three sessions were signiﬁcantly more
likely to be abstinent from alcohol than those receiving no
sessions. If the intervention is to realize its potential, implementation barriers must be addressed.
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Practice implications
In programs using Twelve Step Facilitation, addiction professionals’ routine practices to connect rural veterans with MHG
members and meetings are effective. RAIR did not have additional
beneﬁts, possibly because of implementation challenges.
Informed consent and patient details: I conﬁrm all patient/
personal identiﬁers have been removed or disguised so the patient/
person(s) described are not identiﬁable and cannot be identiﬁed
through the details of the story.
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